No results, please enter a search term above
For the 2026 season, the Philadelphia Department of Public Health (PDPH) has identified 4 neuroinvasive West Nile virus (WNV) infections in Philadelphia, including 1 death. One presumptive viremic donor was also identified.
The WNV pool positivity in 2026 is higher than the year-to-date historic median rate from 2001-2025 (29% vs 9%) and similar to rates observed in 2010, 2018, and 2022 (23%-46%), peak WNV activity seasons in Philadelphia. Increased risk for human infection will continue in Philadelphia until the first hard frost occurs.
From May through October, PDPH, in collaboration with the PA Department of Environmental Protection, conducts mosquito management activities throughout Philadelphia, which entails surveillance and identification of mosquito pools, testing pools for WNV, and control activities (eliminating breeding sites, larviciding catch basins, ground spraying, etc.). Since May 2026, 140 mosquito larvicide treatment events have been conducted across Philadelphia, and 16 locations were treated to control adult mosquito populations.
Click here to download the latest 2026 West Nile Virus report in a printable format.
Counts |
Week 34 (8/23 - 8/29) |
2026 Season (5/1 - 8/29) |
|---|---|---|
|
Mosquito Pools Tested^ |
86 |
482 |
|
WNV Positive Pools |
42 |
140 |
|
Human WNV Cases |
0 |
4 |
|
Neuroinvasive WNV |
0 |
4 |
|
WNV Fever |
0 |
0 |
|
Human WNV Deaths |
0 |
1 |
|
Presumptive Viremic Donors |
0 |
1 |
^482 mosquito pools at 91 different mosquito trapping sites

Advise your patients to:
WNV Testing and Reporting Requirements for Human Surveillance in Philadelphia: